National Health Investors, Inc. (NYSE:NHI – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the nine analysts that are presently covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $82.25.
A number of equities research analysts recently issued reports on the stock. National Bank Financial set a $79.00 price objective on shares of National Health Investors in a report on Wednesday, September 9th. Weiss Ratings cut National Health Investors from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, September 25th. Huntington began coverage on National Health Investors in a research note on Thursday, September 10th. They set an “outperform” rating and a $79.00 price target for the company. BMO Capital Markets reissued an “outperform” rating on shares of National Health Investors in a report on Wednesday, September 23rd. Finally, Zacks Research raised National Health Investors from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 29th.
View Our Latest Report on National Health Investors
Institutional Trading of National Health Investors
National Health Investors Price Performance
Shares of NHI opened at $64.81 on Friday. The firm has a market cap of $3.18 billion, a PE ratio of 18.73, a PEG ratio of 3.45 and a beta of 0.49. The firm’s 50 day moving average price is $70.29 and its 200 day moving average price is $74.88. The company has a debt-to-equity ratio of 0.81, a quick ratio of 6.78 and a current ratio of 6.78. National Health Investors has a twelve month low of $63.51 and a twelve month high of $91.38.
National Health Investors (NYSE:NHI – Get Free Report) last posted its earnings results on Monday, August 10th. The real estate investment trust reported $1.19 EPS for the quarter. The company had revenue of $121.32 million during the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The business’s revenue was up 1.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.22 earnings per share. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, research analysts expect that National Health Investors will post 4.76 EPS for the current fiscal year.
National Health Investors Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, November 6th. Shareholders of record on Wednesday, September 30th will be given a dividend of $0.92 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.68 dividend on an annualized basis and a yield of 5.7%. National Health Investors’s dividend payout ratio is presently 108.67%.
About National Health Investors
National Health Investors, Inc (NYSE:NHI) is a self-managed real estate investment trust that owns and finances healthcare-related real estate. The company primarily invests in properties used by seniors and patients, including senior housing communities, skilled nursing facilities, medical office buildings and other healthcare facilities.
NHI generally leases its properties to healthcare operators under long-term agreements and may provide mortgage or other financing to support the development and operation of healthcare real estate.
Featured Stories
- Five stocks we like better than National Health Investors
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.
